These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 25227811)
1. A cyclin D1 (CCND1) gene polymorphism contributes to susceptibility to papillary thyroid cancer in the Turkish population. Aytekin T; Aytekin A; Maralcan G; Gokalp MA; Ozen D; Borazan E; Yilmaz L Asian Pac J Cancer Prev; 2014; 15(17):7181-5. PubMed ID: 25227811 [TBL] [Abstract][Full Text] [Related]
2. CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population. Chen X; Zhao T; Li L; Xu C; Zhang X; Tse V; Zhang T; Liu X; Lu F DNA Cell Biol; 2012 Jun; 31(6):1107-13. PubMed ID: 22304571 [TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysis. Liao D; Wu Y; Pu X; Chen H; Luo S; Li B; Ding C; Huang GL; He Z PLoS One; 2014; 9(11):e113299. PubMed ID: 25409185 [TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 G870A polymorphism and the risk of hepatocellular carcinoma in a Chinese population. Hu Z; Zhou Z; Xiong G; Wang Y; Lai Y; Deng L; Yang J Tumour Biol; 2014 Jun; 35(6):5607-12. PubMed ID: 24570185 [TBL] [Abstract][Full Text] [Related]
5. CCND1 G870A polymorphism and cervical cancer risk: a case-control study and meta-analysis. Ni J; Wang M; Wang M; Fu S; Zhou D; Zhang Z; Han S J Cancer Res Clin Oncol; 2011 Mar; 137(3):489-94. PubMed ID: 20473525 [TBL] [Abstract][Full Text] [Related]
6. Potential role of CCND1 G870A genotype as a predictor for urothelial carcinoma susceptibility and muscle-invasiveness in Taiwan. Lin HH; Ke HL; Hsiao KH; Tsai CW; Wu WJ; Bau DT; Chang LL Chin J Physiol; 2011 Jun; 54(3):196-202. PubMed ID: 21789902 [TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx. Rydzanicz M; Golusinski P; Mielcarek-Kuchta D; Golusinski W; Szyfter K Eur Arch Otorhinolaryngol; 2006 Jan; 263(1):43-8. PubMed ID: 16258756 [TBL] [Abstract][Full Text] [Related]
8. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer. Bedewy AM; Mostafa MH; Saad AA; El-Maghraby SM; Bedewy MM; Hilal AM; Kandil LS J BUON; 2013; 18(1):227-38. PubMed ID: 23613410 [TBL] [Abstract][Full Text] [Related]
9. Functional role of CyclinD1 polymorphism (G870A) in modifying susceptibility and overall survival of North Indian lung cancer patients. Pandey A; Bahl C; Sharma S; Singh N; Behera D Tumori; 2018 Jun; 104(3):179-187. PubMed ID: 30086699 [TBL] [Abstract][Full Text] [Related]
10. Breast cancer and cyclin D1 gene polymorphism in Turkish women. Yaylim-Eraltan I; Ergen A; Görmüs U; Arikan S; Küçücük S; Sahin O; Yigit N; Yildiz Y; Isbir T In Vivo; 2009; 23(5):767-72. PubMed ID: 19779113 [TBL] [Abstract][Full Text] [Related]
11. [Correlation analysis of G870A CCND1 gene polymorphism with digestive system tumors]. Yang SM; Shi YL Nan Fang Yi Ke Da Xue Xue Bao; 2016 Nov; 36(11):1589-1592. PubMed ID: 27881356 [TBL] [Abstract][Full Text] [Related]
12. The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population. Yaylim-Eraltan I; Arikan S; Yildiz Y; Cacina C; Ergen HA; Tuna G; Görmüs U; Zeybek U; Isbir T Anticancer Res; 2010 Jul; 30(7):2875-80. PubMed ID: 20683026 [TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. Zheng Y; Shen H; Sturgis EM; Wang LE; Eicher SA; Strom SS; Frazier ML; Spitz MR; Wei Q Carcinogenesis; 2001 Aug; 22(8):1195-9. PubMed ID: 11470749 [TBL] [Abstract][Full Text] [Related]
14. Association of cyclin D1 genotypes with nasopharyngeal carcinoma risk. Shih LC; Tsai CW; Tsai MH; Tsou YA; Chang WS; Li FJ; Lee MH; Bau DT Anticancer Res; 2012 Mar; 32(3):1093-8. PubMed ID: 22399638 [TBL] [Abstract][Full Text] [Related]
15. Influence of CCND1 G870A polymorphism on the risk of HBV-related HCC and cyclin D1 splicing variant expression in Chinese population. Zeng Z; Tu J; Cheng J; Yao M; Wu Y; Huang X; Xie X; Zhang X; Lu F; Chen X Tumour Biol; 2015 Sep; 36(9):6891-900. PubMed ID: 25851350 [TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 G870A polymorphism is associated with risk and clinicopathologic characteristics of bladder cancer. Yuan L; Gu X; Shao J; Wang M; Wang M; Zhu Q; Zhang Z DNA Cell Biol; 2010 Oct; 29(10):611-7. PubMed ID: 20575692 [TBL] [Abstract][Full Text] [Related]
17. Association of cyclin D1 (G870A) polymorphism with susceptibility to esophageal and gastric cardiac carcinoma in a northern Chinese population. Zhang J; Li Y; Wang R; Wen D; Sarbia M; Kuang G; Wu M; Wei L; He M; Zhang L; Wang S Int J Cancer; 2003 Jun; 105(2):281-4. PubMed ID: 12673692 [TBL] [Abstract][Full Text] [Related]
18. The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis. Xie M; Zhao F; Zou X; Jin S; Xiong S Medicine (Baltimore); 2017 Oct; 96(42):e8269. PubMed ID: 29049220 [TBL] [Abstract][Full Text] [Related]
19. Role of Caspase 8, Caspase 9 and Bcl-2 polymorphisms in papillary thyroid carcinoma risk in Han Chinese population. Wang YX; Zhao L; Wang XY; Liu CM; Yu SG Med Oncol; 2012 Dec; 29(4):2445-51. PubMed ID: 22120515 [TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer. Wang L; Habuchi T; Takahashi T; Mitsumori K; Kamoto T; Kakehi Y; Kakinuma H; Sato K; Nakamura A; Ogawa O; Kato T Carcinogenesis; 2002 Feb; 23(2):257-64. PubMed ID: 11872630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]